Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,765 across all filing types
Latest filing 2023-07-20 Regulatory Filings
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchanges (BSE and NSE) disclosing information under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the approval of a Scheme of Amalgamation by the National Company Law Tribunal involving subsidiaries of a related entity. The document is short (1689 characters) and serves as a regulatory disclosure of a corporate event (merger approval) rather than a full merger filing or detailed report. It does not contain financial statements or detailed merger documentation, nor is it a proxy, voting result, or management report. It is an announcement of a corporate event relevant to investors and regulators. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-07-20 English
In furtherance to our earlier intimation dated 31st July, 2021, we wish to inform you that the National Company Law Tribunal, Mumbai vide its order dated 22nd June, 2023, the certified ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchanges (BSE and NSE) disclosing information under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the approval of a Scheme of Amalgamation by the National Company Law Tribunal involving subsidiaries of a related entity. The document is short (1689 characters) and serves as a regulatory disclosure rather than a detailed report or financial statement. It does not contain financial data, management discussion, or detailed analysis. It is an announcement of a corporate event (merger approval) relevant to shareholders and regulators. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-07-20 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the loss of share certificates and the issuance of duplicate share certificates. It references Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss and related disclosures. The content includes details of shareholders, folio numbers, certificate numbers, and distinctive share numbers. There is no financial data, earnings information, or management discussion. The document is a regulatory announcement informing the exchanges and market participants about the loss of share certificates to prevent trading in those shares. This fits the category of a Regulatory Filing (RNS) as it is a compliance-related disclosure that does not fit into other specific categories like financial reports or management changes.
2023-07-19 English
Intimation of Loss of Share Certificates
Regulatory Filings
2023-07-19 English
We hereby inform that the Company has scheduled a teleconference with Investors / Analyst on 7th August, 2023 at 06:00 P.M. to discuss the financial performance of the Company for the ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange (BSE Limited) announcing a post quarterly financial result conference call scheduled for August 7, 2023, to discuss the financial performance for the quarter ended June 30, 2023. It provides dial-in details for the call and is signed by the company secretary. The document does not contain actual financial data or detailed financial statements but is an announcement of an upcoming event related to quarterly results. The document length is short (2165 characters), and it serves as a notification rather than a report or transcript. Therefore, it fits best under the category of a Call Transcript (CT) announcement, but since it is only announcing the call and not providing the transcript, it is more appropriate to classify it as a Regulatory Filing (RNS) as a general regulatory announcement about the conference call. Confidence is high due to clear context and content.
2023-07-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 90% confidence The document is a letter addressed to the stock exchange (BSE Limited) announcing a post quarterly financial result conference call scheduled for August 7, 2023, to discuss the financial performance for the quarter ended June 30, 2023. It provides dial-in details for the call but does not contain any financial data or analysis itself. The document length is short (2207 characters) and it serves as an announcement of the conference call rather than the transcript or the financial report. Therefore, it fits the category of a Call Transcript announcement or notification. However, since it is only announcing the call and not the transcript itself, the best fitting category is Regulatory Filings (RNS) as a general regulatory announcement about the call. Confidence is high due to clear context and document content.
2023-07-19 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.